Edukasi dan Deteksi Dini Kadar HDL dan Kolesterol dalam Rangka Menjaga Kualitas Kesehatan pada Populasi Lansia di Panti Werda Hana
DOI:
https://doi.org/10.58374/jmmn.v4i2.342Keywords:
Early-Detection, Elderly, High-Density-Lipoprotein, Screening, Total-CholesterolAbstract
Hypercholesterolemia is one of the health problems that is often experienced by the elderly and has a major impact on their quality of life, especially because it increases the risk of cardiovascular diseases such as coronary heart disease, stroke, and peripheral vascular disorders. This condition often does not show symptoms, but the process of atherosclerosis can develop slowly and cause serious complications if not treated early. The Community Service Program (PKM) implemented at Panti Werdha Hana aims to increase awareness among the elderly of the importance of early detection of Cholesterol and High Density Lipoprotein (HDL) levels as part of efforts to prevent heart disease. This activity applies the Plan-Do-Check-Act (PDCA) approach, including total cholesterol and HDL examinations using the Point-of-Care Testing (POCT) method, as well as interactive education about risk factors and healthy lifestyles. The results of the activity showed that out of 76 participants, 38 people (50%) had total cholesterol levels above normal, while 22 people (28.95%) had low or very low HDL levels. Early detection through screening has proven effective in identifying cardiovascular risks earlier and providing a basis for timely medical and educational interventions. Through this activity, it is hoped that the elderly can understand their health conditions better and take preventive steps to maintain lipid levels within normal limits, to improve the quality of life and reduce the risk of cardiovascular complications in the future.
References
Achila, O. O., Araya, M., Berhe, A. B., Haile, N. H., Tsige, L. K., Shifare, B. Y., Bitew, T. A., Berhe, I. E., Mengistu, S. T., & Yohaness, E. G. (2021). Dyslipidemia and associated risk factors in the elderly population in Asmara, Eritrea: Results from a community-based cross-sectional study. Journal of Lipids, 2021, 1–13. https://doi.org/10.1155/2021/6155304
Anggraini, D., & Hasni, D. (2021). Early detection of hypercholesterolemia in the elderly. Jurnal Abdimas Saintika, 3(2), 7–12. https://doi.org/10.30633/jas.v3i2.1173
Antza, C., Rizos, C. V., Kotsis, V., Liamis, G., Skoumas, I., Rallidis, L., Garoufi, A., Kolovou, G., Tziomalos, K., Skalidis, E., Sfikas, G., Doumas, M., Lambadiari, V., Anagnostis, P., Stamatelopoulos, K., Anastasiou, G., Koutagiar, I., Kiouri, E., Kolovou, V., … Liberopoulos, E. (2024). Familial hypercholesterolemia in the elderly: An analysis of clinical profile and atherosclerotic cardiovascular disease burden from the Hellas-FH registry. Biomedicines, 12(1), Article 231. https://doi.org/10.3390/biomedicines12010231
Chung, K. W. (2021). Advances in understanding of the role of lipid metabolism in aging. Cells, 10(4), Article 880. https://doi.org/10.3390/cells10040880
Félix-Redondo, F. J., Grau, M., & Fernández-Bergés, D. (2013). Cholesterol and cardiovascular disease in the elderly: Facts and gaps. Aging and Disease, 4(3), 154–169. http://www.ncbi.nlm.nih.gov/pubmed/23730531
Ibrahim, M. A., Asuka, E., & Jialal, I. (2024). Hypercholesterolemia. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/pubmed/30156604
Kosmas, C. E., Martinez, I., Sourlas, A., Bouza, K. V., Campos, F. N., Torres, V., Montan, P. D., & Guzman, E. (2018). High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs in Context, 7, 1–9. https://doi.org/10.7573/dic.212525
Lee, Y., & Siddiqui, W. J. (2024). Cholesterol levels. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/pubmed/4337382
Leiherer, A., Ulmer, H., Muendlein, A., Saely, C. H., Vonbank, A., Fraunberger, P., Foeger, B., Brandtner, E. M., Brozek, W., Nagel, G., Zitt, E., Drexel, H., & Concin, H. (2021). Value of total cholesterol readings earlier versus later in life to predict cardiovascular risk. EBioMedicine, 67, 103371. https://doi.org/10.1016/j.ebiom.2021.103371
Pappan, N., & Rehman, A. (2024). Dyslipidemia. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/pubmed/8185133
Qu, C., Liao, S., Zhang, J., Cao, H., Zhang, H., Zhang, N., Yan, L., Cui, G., Luo, P., Zhang, Q., & Cheng, Q. (2024). Burden of cardiovascular disease among elderly: Based on the Global Burden of Disease Study 2019. European Heart Journal - Quality of Care and Clinical Outcomes, 10(2), 143–153. https://doi.org/10.1093/ehjqcco/qcad033
Ramayanti, I., Mayasari, N. M. E., Rosita, Y., Prameswarie, T., Ghiffari, A., Suarni, E., Indriyani, I., Oktariza, R. T., Erlyn, P., Anggina, D. N., Zalika, P., Asmalia, R., & Chairani, L. (2022). Cardiovascular disease risk detection through cholesterol examination. Indonesia Berdaya, 3(3), 479–484. https://doi.org/10.47679/ib.2022242
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., Bonny, A., Brauer, M., Brodmann, M., Cahill, T. J., Carapetis, J., Catapano, A. L., Chugh, S. S., Cooper, L. T., Coresh, J., … Fuster, V. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Zhou, M., Zhao, G., Zeng, Y., Zhu, J., Cheng, F., & Liang, W. (2022). Aging and cardiovascular disease: Current status and challenges. Reviews in Cardiovascular Medicine, 23(4), 135. https://doi.org/10.31083/j.rcm2304135
